Calendar Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
959.9 USD -0.47% Intraday chart for Regeneron Pharmaceuticals, Inc. -0.47% +9.29%

Chart calendar Regeneron Pharmaceuticals, Inc.

6bf5.g4h3WzEgFw3_y12krQRzKoqsZLpwWh5RADLo_QB_9Ck.1KUCF3ARSF-uvW_pyFAgc8jgVvIcMH0hMluwxWEowkDS7xgKdVYmeKmIZQ~5b309ed9eb32557487abbf22809f63ac

Upcoming events on Regeneron Pharmaceuticals, Inc.

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-01-30 Q4 2024 Earnings Release (Projected)

Past events on Regeneron Pharmaceuticals, Inc.

2024-03-13 10:40 am Leerink Partners Global Biopharma Conference
2024-03-12 11:15 am Barclays Global Healthcare Conference
2024-03-06 11:10 am TD Cowen Health Care Conference
2024-02-14 01:20 pm Oppenheimer Healthcare Life Sciences Conference
2024-02-02 08:30 am Q4 2023 Earnings Call
2024-02-02 06:30 am Q4 2023 Earnings Release
2024-01-08 05:15 pm JPMorgan Healthcare Conference
2023-12-14 08:30 am Business Update Call
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No 3841
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No 4746
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No 4461
2023-12-11 American Society of Hematology Meeting - Abstract No 912
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No 4504
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No 2550
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No 2716
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No 3752
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No 3773
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No 3393
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No 3359
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No 3100

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
7 863
7 816
0.61%
8 497
8 494
0.04%
16 072
15 679
2.51%
12 173
11 850
2.73%
13 117
12 921
1.52%

13 886

EBITDA
Million USD
Released
Forecast
Spread
3 420
3 610
-5.28%
4 245
4 158
2.09%
9 835
9 709
1.29%
6 060
6 161
-1.63%
5 547
5 452
1.74%

5 599

EBIT
Million USD
Released
Forecast
Spread
2 210
2 285
-3.29%
3 577
3 485
2.64%
8 947
9 034
-0.96%
5 719
5 561
2.84%
5 126
5 082
0.87%

5 262

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
2 429
2 308
5.26%
3 810
3 582
6.39%
9 326
9 442
-1.23%
4 859
4 812
0.97%
4 199
4 276
-1.8%

4 770

Net income
Million USD
Released
Forecast
Spread
2 116
1 998
5.87%
3 513
3 160
11.18%
8 075
8 014
0.77%
4 338
4 166
4.14%
3 954
3 808
3.83%

4 164

EPS
USD
Released
Forecast
Spread
18,5
17,6
4.67%
30,5
28,0
8.96%
72,0
71,1
1.17%
38,2
36,3
5.31%
34,8
33,9
2.62%

36,7

Announcement Date06/02/2005/02/2104/02/2203/02/2302/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
4 952
4 526
9.4%
2 965
2 690
10.22%
2 857
2 797
2.14%
2 936
2 870
2.29%
3 414
3 113
9.7%
3 162
2 998
5.48%
3 158
3 025
4.41%
3 363
3 222
4.36%
3 434
3 287
4.49%

3 208


3 389


3 553


3 715


3 776

EBITDA
Million USD
Released
Forecast
Spread
2 903
2 564
13.21%
1 558
1 376
13.24%
1 344
1 220
10.17%
1 488
1 344
10.67%
1 637
1 336
22.54%
1 315
1 219
7.84%
1 351
1 175
14.98%
1 488
1 288
15.47%
1 395
1 500
-7.01%

1 171


1 293


1 422


1 547




EBIT
Million USD
Released
Forecast
Spread
2 640
2 601
1.5%
1 483
1 273
16.56%
1 285
1 124
14.37%
1 413
1 266
11.62%
1 537
1 344
14.33%
1 215
1 203
1.01%
1 248
1 216
2.63%
1 382
1 272
8.7%
1 282
1 248
2.74%

1 119


1 247


1 342


1 386




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
2 503
2 649
-5.51%
1 061
1 185
-10.43%
963
1 116
-13.71%
1 510
984
53.36%
1 325
1 154
14.81%
858
1 009
-14.97%
1 083
1 041
4%
1 111
1 154
-3.72%
1 148
1 308
-12.24%

1 212


1 304


1 432


1 287




Net income
Million USD
Released
Forecast
Spread
2 229
2 108
5.74%
974
1 038
-6.2%
852
794
7.38%
1 316
845
55.67%
1 197
1 060
12.94%
818
876
-6.69%
968
885
9.42%
1 008
1 071
-5.9%
1 160
1 025
13.08%

890


1 025


1 105


1 155


1 283

EPS
USD
Released
Forecast
Spread
19,7
19,4
1.32%
8,61
8,77
-1.86%
7,47
7,38
1.29%
11,7
7,93
47.05%
10,5
9,23
13.73%
7,17
7,96
-9.92%
8,50
7,93
7.12%
8,89
9,04
-1.62%
10,2
9,21
10.69%

7,94


9,36


9,94


9,70


11,5

Announcement Date04/02/2204/05/2203/08/2203/11/2203/02/2304/05/2303/08/2302/11/2302/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise